SC Filed 2021-11-23 Event — SEC 0001104659-21-143101 →

He Wei-Wu → CASI Pharmaceuticals, Inc.

Stake: — Shares: —

Composite Decision Signal · PASS (LOW BASE-RATE EDGE) Conviction Score: 2/100 · Filer 90d Win Rate: 33% · Hist. 90d Edge: -39.8%

Filer track record (4 filings): 33% 90d win rate, -39.8% 90d edge

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

0 transactions

0 buys · 0 sales · 0 awards/exercises

Issuer Cluster

8 13D/G filings on this issuer

7 other filings besides this one

Filer Track Record

8 filings by this filer

7 other filings in the data moat

Short Interest

—

Not in latest FINRA snapshot

Other 13D/G Filings on CASI Pharmaceuticals, Inc.

Filed	Form	Filer	Stake	Shares
2023-02-21	SC	Ho Chi Sing	—	—	view →
2021-04-30	SC	SPECTRUM PHARMACEUTICALS INC	—	—	view →
2021-02-03	SC	He Wei-Wu	—	—	view →
2020-03-24	SC	He Wei-Wu	—	—	view →
2018-05-14	SC	SPECTRUM PHARMACEUTICALS INC	—	—	view →
2018-04-04	SC	He Wei-Wu	—	—	view →
2018-03-20	SC	Ho Chi Sing	—	—	view →

Other Filings by He Wei-Wu

Filed	Form	Issuer	Stake	Shares
2026-05-18	SCHEDULE 13D/A	CASI Pharmaceuticals, Inc. CASIF	—	23,985,535	view →
2026-01-29	SCHEDULE	CASI Pharmaceuticals, Inc. CASIF	34.80%	8,965,535	view →
2026-01-09	SCHEDULE	CASI Pharmaceuticals, Inc. CASIF	19.10%	3,965,535	view →
2025-06-20	SCHEDULE	CASI Pharmaceuticals, Inc. CASIF	23.80%	3,735,535	view →
2021-02-03	SC	CASI Pharmaceuticals, Inc.	—	—	view →
2020-03-24	SC	CASI Pharmaceuticals, Inc.	—	—	view →
2018-04-04	SC	CASI Pharmaceuticals, Inc.	—	—	view →

Want this depth on every filing the moment it hits SEC EDGAR?

Free $0 (48h-delayed alerts) · Individual $49/mo (real-time) · Team & API $199/mo · Enterprise.

See pricing →